Photoprotection Habits in Patients With Vitiligo
NCT03323125 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2018-06-26
Summary
Intro:
Patients with vitiligo have a reduced protection on depigmented areas. To date, however, little is known about photoprotection habits in patients with vitiligo even though these patients are thought to have a decreased ability to efficiently protect their skin against sun damage. Moreover, exposure to artificial UV is one of the major elements of the treatment of vitiligo even though certain phenotypes of vitiligo could be photoinduced.
Hypothesis The Primary objective is to describe patients behaviour with sun exposition
The Secondary objectives are:
* to assess the link between sun exposition and vitiligo outbreaks
* to assess photoprotection habits according to initial phototype and vitiligo severity (SA-VES)
* To validate a short form of the VIPs questionnaire, a validated burden questionnaire.
Method We aim to conduct a prospective cross sectional study in patients with Vitiligo with the aim to evaluate sun protection habits in patients with vitiligo. For that purpose a semi-directed questionnaire to investigate the sun protection behavior of vitiligo patients (adults\> 18 years of age) have been created by experts in the field. Vitiligo severity will be self-assessed by patients using a recently validated patient reported outcome, the SA-VES. Consecutive vitiligo patients consulting in the dermatology department of Henri Mondor Hospital (Créteil, France) will be proposed to participate the study after having given their oral consent. We are planning to enrol 500 patients.
In a first step, a descriptive analysis will be carried out in order to describe the characteristics of the sample. Basic summary statistics, such as proportions, means and standard deviations, will be used to characterize the population. In order to identify the factors associated with the severity of the disease on the one hand and the phototype on the other, comparisons between groups (severe versus non-severe and light phototype versus dark phototype) will be carried out by unconditional logistic regression. All potential predictors of severity will first be assessed individually, and Odds Ratio (OR), corresponding 95% CIs and P values will be calculated. The significance of the OR will be determined by the Wald test χ2, and the predictors with P \<.20 will then be evaluated using a multivariate analysis with a pre-selection procedure. Possible interactions and multi-colinearity will be examined. Finally, the quality of fit of the final model will be evaluated using the logistic regression diagnostic procedure. P ≤ 0.05 will be considered as statistically significant. The Hosmer-Lemeshow test will be carried out to test the suitability of the model.
Conclusion This study will help to identify gaps in the knowledge of sun protection habits in patients with vitiligo.
Conditions
- Vitiligo
- PHOTOPROTECTION
- SUN-EXPOSITION
- FITZPATRICK SCALE
Interventions
- OTHER
-
Self-Assessment Questionnaire
Self-assessment questionnaire with sun exposition, sun protection, vitiligo severity and vitiligo outbreaks, will be suggested to patient during medical consultation.
Sponsors & Collaborators
-
Assistance Publique - Hôpitaux de Paris
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-10-16
- Primary Completion
- 2018-04-16
- Completion
- 2018-04-16
Countries
- France
Study Locations
More Related Trials
-
Translational Assessment of Vitiligo According to Body Locations
NCT06068218 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Serological Markers of Vitiligo Activity
NCT06731283 ·Status: ACTIVE_NOT_RECRUITING
-
Epidermal Cell Transplantation in Vitiligo Skin
NCT01629979 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Online Health Survey of Patients With Vitiligo Vulgaris/ Online Survey of Pediatric Patients With Vitiligo
NCT01401374 ·Status: COMPLETED
-
Building an Assessment Model for Vitiligo Activity and Prognosis Using Peripheral Blood Cytokine Profiles
NCT07298551 ·Status: NOT_YET_RECRUITING
-
Assessment of Circulating Fubctional Mitochondrias in Vitiligo Patients
NCT05525741 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Human Beta-defensin 1 in Vitiligo
NCT03832751 ·Status: UNKNOWN ·Phase: NA
-
XPAND Trial: Enhancing XP Photoprotection Activities - New Directions
NCT03445052 ·Status: COMPLETED ·Phase: NA
-
Deciphering the Vitiligo Transcriptomic Signature Between Repigmented and Non Repigmented Lesions
NCT05927272 ·Status: RECRUITING ·Phase: NA
-
Insulin Like Growth Factor-1 Against Oxidative Stress in Vitiligo
NCT05812079 ·Status: NOT_YET_RECRUITING
-
Tissue-resident Memory T Cells Expression Among the Repigmentation Patterns Induced by NB-UVB Phototherapy in Vitiligo
NCT05506995 ·Status: COMPLETED
-
ERASE VITILIGO Early Repigmentation Approach for Stopping the Evolution of VITILIGO Prospective Multicentric Interventional Study With Blinded Evaluation
NCT04843059 ·Status: COMPLETED ·Phase: NA
-
Questionnaire and Laboratory Data on Vitiligo Vulgaris
NCT01206374 ·Status: COMPLETED
-
Investigating Healthcare Disparities in Vitiligo
NCT06097494 ·Status: COMPLETED
-
Patient Reported Outcomes With UVA-1 Therapy for Treatment of Sclerosing Skin Diseases
NCT04922736 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Evaluation of Serum Interleukin-15 and Interleukin-22 Levels in Patients With Non-segmental Vitiligo
NCT05121532 ·Status: UNKNOWN ·Phase: NA
-
The Gut and Skin Microbiome in Vitiligo Disease Progression
NCT03577327 ·Status: RECRUITING
-
Study of Applications of Autologous Epidermal Cells in Liquid Phase in the Treatment of Vitiligo
NCT01511965 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Vitiligo Treatment by Targeting TYK2 Mediated Responses
NCT06327321 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Pilot Cohort Study of Risk Factors and Novel Methods of Skin Lesion Assessments in Adults With Atopic Dermatitis, Alopecia Areata, Psoriasis or Vitiligo
NCT06319781 ·Status: RECRUITING
-
Evaluation of Serum Gasdermin D Level As a Potential Biomarker of Disease Activity in Vitiligo Patients
NCT06584643 ·Status: NOT_YET_RECRUITING
-
Vitiligo, New Treatment and Serum s100B
NCT06768840 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Leucotrichia in Vitiligo
NCT03402633 ·Status: COMPLETED
-
ASSESSMENT OF TRISTETRAPROLIN EXPRESSION IN LESIONAL SKIN OF PATIENTS WITH NON SEGMENTAL VITILIGO
NCT05990309 ·Status: UNKNOWN ·Phase: NA
-
IL35 Level in Vitiligo
NCT05980390 ·Status: UNKNOWN